Abstract
The behavioral actions of some novel aporphines have been examined in rats with selective unilateral 6-hydroxydopamine (6OHDA)-induced destruction of nigrostriatal dopaminergic neurons, and in rats with bilateral 6OHDA-induced destruction of mesolimbic dopaminergic neurons. Dopaminomimetics such as apomorphine (APO) in these animal models elicit circling behavior and locomotor activity respectively. In animals with unilateral nigrostriatal lesions (-)-2,10,11-trihydroxy-N-n-propylnoraporphine (TNPA) and (-)-10,11-methylenedioxy-N-n-propylnoraporphine (MDO-NPA) elicited weak, but prolonged, contraversive circling, whereas (-)-2,10,11-trihydroxyaporphine (2-OH.APO) was inactive. In animals with bilateral destruction of mesolimbic dopaminergic neurons TNPA and MDO-NPA elicited a strong stimulation of locomotor activity, while 2-OH.APO was inactive. The results suggest that TNPA and MDO-NPA, but not 2-OH.APO, exert central dopaminomimetic effects in vivo. The results are also consistent with previous data indicating that N-propyl substitution of aporphines causes a relative enhancement of activity in animal models which emphasise effects at mesolimbic rather than striatal dopaminergic receptors.
References
Feb 1, 1978·The Journal of Pharmacy and Pharmacology·J Pearl
Jan 15, 1978·European Journal of Pharmacology·C J Pycock, C D Marsden
May 5, 1978·Science·C A TammingaJ M Davis
Nov 24, 1977·Psychopharmacology·P H Kelly, K E Moore
Feb 1, 1977·Journal of Medicinal Chemistry·B Costall, R J Naylor
Apr 1, 1977·Experimental Neurology·E S TolosaK E Dahl
Jan 1, 1976·Journal of Medicinal Chemistry·J L NeumeyerL Agnati
Jan 1, 1976·European Journal of Pharmacology·R J MillerJ L Neumeyer
Oct 21, 1976·Nature·P H Kelly, K E Moore
Nov 1, 1976·European Journal of Pharmacology·P H Kelly, S D Iversen
Mar 11, 1976·The New England Journal of Medicine·G C CotziasM Bell-Midura
Jun 1, 1975·Life Sciences·J S MendezK Dahl
Mar 1, 1975·European Journal of Pharmacology·B CostallJ L Neumeyer
Sep 5, 1975·Brain Research·P H KellyS D Iversen
Jan 1, 1976·European Journal of Pharmacology·P H KellyJ L Neumeyer
Oct 1, 1974·Life Sciences·E S Tolosa, S B Sparber
Feb 1, 1974·Journal of Neurochemistry·A S HornR J Miller
Jan 1, 1970·The New England Journal of Medicine·G C CotziasI Mena
Jan 8, 1982·European Journal of Pharmacology·R J BaldessariniN S Kula
Oct 1, 1982·Neuropharmacology·A CampbellJ L Neumeyer
Jul 1, 1981·Journal of Medicinal Chemistry·J L NeumeyerK J Watling
Dec 1, 1981·Journal of Medicinal Chemistry·J L NeumeyerR J Baldessarini
Dec 1, 1981·Biochemical Pharmacology·G W AranaM Harding
Citations
Jan 1, 1983·Psychopharmacology·G M AnlezarkJ L Neumeyer
Nov 14, 1983·Brain Research·E A Jackson, P H Kelly
Aug 1, 1985·Neuropharmacology·E A JacksonL Schultz
May 1, 1985·Neuropharmacology·A CampbellJ L Neumeyer
Feb 1, 1986·Pharmacology, Biochemistry, and Behavior·R BoldryN J Uretsky
Dec 31, 1993·Behavioural Brain Research·R J MandelP K Randall
Mar 1, 1991·Brain Research. Molecular Brain Research·H M Chao, B S McEwen
Nov 1, 1983·Brain Research Bulletin·E A Jackson, P H Kelly
Sep 1, 1983·Brain Research Bulletin·S L Hartgraves, P H Kelly
Mar 31, 1999·Psychoneuroendocrinology·C J McDougleL H Price
Jul 1, 1992·Comprehensive Psychiatry·D J SteinE Hollander
Jan 21, 2012·Pharmacology, Biochemistry, and Behavior·Catherine M ClaussenNachum Dafny
Jan 1, 1989·Psychopharmacology·M Sarter, T Steckler
Feb 20, 2020·Behavioural Brain Research·Rahul BharatiyaFabrizio Sanna